| ID | PMID | SEQUENCE | NAME | LENGTH | ACTIVITY |
| 1525 | 16637646 | LLGDFFRKSKEK | LL-37(1-12) | 12 | Not Available |
| 1526 | 16637646 | IGKEFKRIVQRIKDFLRNLVPRTES | LL-37(13-37) | 25 | LC50=39 µM |
| 1527 | 16637646 | FKRIVQRIKDFLRNLV | LL-37(17-32)b | 16 | LC50=30 µM |
| 1528 | 16637646 | FKRIVQRIKDFLR | LL-37(17-29) | 13 | LC50=60 µM |
| 1529 | 16637646 | LLGDFKRIVQRIKDF | LL-37(1-4,17-27) | 15 | Not Available |
| 1530 | 16637646 | FKRiVQRiKDFlRNLV | dLL-37(17-32)c | 16 | Not Available |
| 1531 | 16637646 | LLGDFFRKSKEK | LL-37(1-12) | 12 | Not Available |
| 1532 | 16637646 | IGKEFKRIVQRIKDFLRNLVPRTES | LL-37(13-37) | 25 | LC50=40 µM |
| 1533 | 16637646 | FKRIVQRIKDFLRNLV | LL-37(17-32)b | 16 | LC50=30 µM |
| 1534 | 16637646 | FKRIVQRIKDFLR | LL-37(17-29) | 13 | LC50=57 µM |
| 1535 | 16637646 | LLGDFKRIVQRIKDF | LL-37(1-4,17-27) | 15 | Not Available |
| 1536 | 16637646 | FKRIVQRIKDFLRNLV | dLL-37(17-32)c | 16 | Not Available |
| 2857 | 22084165 | KLlLKlLkkLLKlLKKK | Lytik | 17 | IC50=37.4 µMol/L |
| 2864 | 22084165 | KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK | IL-4RaÐlytic hybrid peptide | 33 | IC50=13.2 µMol/L |
| 3165 | 17559067 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Peptide 5 | 40 | 10.6 % inhibition of cell proliferation at 1 nM |
| 3166 | 17559067 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Peptide 5 | 40 | 18.2 % inhibition of cell proliferation at 10 nM |
| 3167 | 17559067 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Peptide 5 | 40 | 30.7 % inhibition of cell proliferation at 100 nM |
| 3168 | 17559067 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Peptide 5 | 40 | 43.1 % inhibition of cell proliferation at 1 µM |
| 3169 | 17559067 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Peptide 5 | 40 | 98.3 % inhibition of cell proliferation at 10 µM |
| 3185 | 17559067 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Peptide 5 | 40 | ED50 =2.1 µM |
| 3207 | 22413859 | KVKVKVKVpPTKVKVKVK | SVS-1 | 18 | NA |
| 3219 | 22413859 | kvkvkvkvPptkvkvkvk | D-SVS-1 | 18 | IC50 =4.5±0.5 µM |
| 3223 | 22413859 | KVKVKVKVPPTKVKVKVK | SVS-2 | 18 | IC50 >100 µM |
| 4519 | 22023734 | GRRKRKWLRRIGKGVKIIGGAALDHL | NRC-03 | 26 | 30% cytotoxic at 5 µM |
| 4520 | 22023734 | GRRKRKWLRRIGKGVKIIGGAALDHL | NRC-03 | 26 | 50% cytotoxic at 10 µM |
| 4521 | 22023734 | GRRKRKWLRRIGKGVKIIGGAALDHL | NRC-03 | 26 | 70% cytotoxic at 25 µM |
| 4522 | 22023734 | GRRKRKWLRRIGKGVKIIGGAALDHL | NRC-03 | 26 | 80-85% cytotoxic at 50 µM |
| 4539 | 22023734 | RWGKWFKKATHVGKHVGKAALTAYL | NRC-07 | 25 | ~0% cytotoxic at 5 µM |
| 4540 | 22023734 | RWGKWFKKATHVGKHVGKAALTAYL | NRC-07 | 25 | 20% cytotoxic at 10 µM |
| 4541 | 22023734 | RWGKWFKKATHVGKHVGKAALTAYL | NRC-07 | 25 | 70-80% cytotoxic at 25 µM |
| 4542 | 22023734 | RWGKWFKKATHVGKHVGKAALTAYL | NRC-07 | 25 | 80-85% cytotoxic at 50 µM |
| 4558 | 22023734 | GWRTLLKKAEVKTVGKLALKHYL | NRC-13 | 23 | 10% cytotoxic at 5 µM |
| 4559 | 22023734 | GWRTLLKKAEVKTVGKLALKHYL | NRC-13 | 23 | 10% cytotoxic at 10 µM |
| 4560 | 22023734 | GWRTLLKKAEVKTVGKLALKHYL | NRC-13 | 23 | 10-15% cytotoxic at 25 µM |
| 4561 | 22023734 | GWRTLLKKAEVKTVGKLALKHYL | NRC-13 | 23 | 15-20% cytotoxic at 50 µM |